Jiangfeng Xu

1.2k total citations
18 papers, 486 citations indexed

About

Jiangfeng Xu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Jiangfeng Xu has authored 18 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Jiangfeng Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer-related molecular mechanisms research (3 papers). Jiangfeng Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer-related molecular mechanisms research (3 papers). Jiangfeng Xu collaborates with scholars based in China and United States. Jiangfeng Xu's co-authors include Lian‐Yue Yang, Ruimin Chang, Hao Yang, Feng Fang, Xiyu Liu, Shuai Wang, Yong Cui, Chao Liu, Quan Li and Qiang Shao and has published in prestigious journals such as Hepatology, Cancer and Scientific Reports.

In The Last Decade

Jiangfeng Xu

18 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiangfeng Xu China	11	289	235	93	84	71	18	486
Zhiming Wang China	15	402 1.4×	320 1.4×	80 0.9×	80 1.0×	154 2.2×	32	638
Áron Somorácz Hungary	12	182 0.6×	108 0.5×	67 0.7×	55 0.7×	81 1.1×	22	372
Dianke Chen China	13	299 1.0×	257 1.1×	76 0.8×	54 0.6×	186 2.6×	25	519
Kemin Jin China	10	205 0.7×	121 0.5×	79 0.8×	176 2.1×	249 3.5×	34	502
Carmen Oi‐Ning Leung Hong Kong	8	275 1.0×	173 0.7×	53 0.6×	34 0.4×	101 1.4×	9	399
Jiachu Li China	9	345 1.2×	123 0.5×	35 0.4×	123 1.5×	120 1.7×	12	546
Xiang Ma China	13	281 1.0×	253 1.1×	82 0.9×	16 0.2×	66 0.9×	26	435
Nicole P. Ho Hong Kong	6	265 0.9×	213 0.9×	46 0.5×	29 0.3×	137 1.9×	9	453
Christine Gauglhofer Austria	7	365 1.3×	106 0.5×	53 0.6×	41 0.5×	72 1.0×	7	433

Countries citing papers authored by Jiangfeng Xu

Since Specialization

Citations

This map shows the geographic impact of Jiangfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangfeng Xu more than expected).

Fields of papers citing papers by Jiangfeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangfeng Xu. The network helps show where Jiangfeng Xu may publish in the future.

Co-authorship network of co-authors of Jiangfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangfeng Xu. A scholar is included among the top collaborators of Jiangfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangfeng Xu. Jiangfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Huang, Yan, et al.. (2019). [Prognostic analysis of colon and rectal neuroendocrine neoplasm in different stages].. PubMed. 41(2). 146–151. 1 indexed citations

Xu, Jiangfeng, et al.. (2018). Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines. Molecular Medicine Reports. 17(6). 7672–7682. 11 indexed citations

Liu, Liping, et al.. (2017). Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy. OncoTargets and Therapy. Volume 10. 339–345. 14 indexed citations

Liu, Liping, et al.. (2017). Prognostic value of increased expression of RACO-1 in patients with hepatitis B-related hepatocellular carcinoma. Therapeutics and Clinical Risk Management. Volume 13. 191–200. 1 indexed citations

Cui, Yong, Quan Li, Hua Shen, et al.. (2016). Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis. Scientific Reports. 6(1). 25776–25776. 74 indexed citations

Chang, Ruimin, Jiangfeng Xu, Feng Fang, Hao Yang, & Lian‐Yue Yang. (2016). MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling. Tumor Biology. 37(8). 10609–10619. 51 indexed citations

Chang, Ruimin, Lei Pei, Fang Fěng, et al.. (2016). YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma. Oncotarget. 7(34). 55585–55600. 5 indexed citations

Lei, Xiong, Jiangfeng Xu, Ruimin Chang, et al.. (2016). JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling. Oncotarget. 7(26). 40266–40284. 38 indexed citations

Xu, Jiangfeng, et al.. (2015). Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification. World Journal of Surgical Oncology. 13(1). 86–86. 41 indexed citations

10.

Xu, Jiangfeng, et al.. (2015). Impact of intra-operative intraperitoneal chemotherapy on organ/space surgical site infection in patients with gastric cancer. Journal of Hospital Infection. 91(3). 237–243. 3 indexed citations

11.

Liu, Xiyu & Jiangfeng Xu. (2015). Reduced Histone H3 Acetylation in CD4⁺T Lymphocytes: Potential Mechanism of Latent Autoimmune Diabetes in Adults. Disease Markers. 2015. 1–7. 15 indexed citations

12.

Wang, Shuai, et al.. (2015). Clinicopathological characteristics of unicentric retroperitoneal Castleman’s disease: a study of 14 cases. World Journal of Surgical Oncology. 14(1). 3–3. 10 indexed citations

13.

Xu, Jiangfeng. (2015). Body Mass Index and Waistline are Predictors of Survival for Hepatocellular Carcinoma After Hepatectomy. Medical Science Monitor. 21. 2203–2209. 7 indexed citations

14.

Liu, Xiyu & Jiangfeng Xu. (2014). Liver resection for young patients with large hepatocellular carcinoma: a single center experience from China. World Journal of Surgical Oncology. 12(1). 175–175. 15 indexed citations

15.

Chang, Ruimin, Hao Yang, Feng Fang, Jiangfeng Xu, & Lian‐Yue Yang. (2014). MicroRNA-331–3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology. 60(4). 1251–1263. 140 indexed citations

16.

Xu, Jiangfeng, et al.. (2013). SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial‐mesenchymal transition. Cancer. 119(12). 2247–2257. 30 indexed citations

17.

Yang, Lian‐Yue, et al.. (2013). Hepatectomy for Huge Hepatocellular Carcinoma: Single Institute’s Experience. World Journal of Surgery. 37(9). 2189–2196. 29 indexed citations

18.

Zheng, Hao, Fugui Wang, Jiangfeng Xu, et al.. (2009). Pathway Detection Based on Hierarchical LASSO Regression Model. 1–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact